Pharma Five is a registered firm based in India. We specialize in Named Patient Imports, Imported cancer drugs, Imported medicines in india.
Contact Us Pharma Five Door No. 74, Old No. 26, Fagun Mansion, 3rd Floor, Ethiraj Salai, Egmore, Chennai - 600008 +916374297988 info@pharmafive.org
Medicine name : Libtayo
Generic name : Cemiplimab
Manufactured By : Regeneron
Indications : NSCLC With High PD-L1
Medicine Description : Libtayo is a PD-1 checkpoint inhibitor for cutaneous squamous cell carcinoma (CSCC), NSCLC, and basal cell carcinoma (BCC). It boosts the immune system’s attack on cancer. Given via IV infusion, it offers durable responses. Side effects include immune-related colitis, pneumonitis, and liver inflammation. Close immune toxicity monitoring is essential.
Libtayo (Cemiplimab) is a prescription drug used to treat certain types of cancer, including advanced cutaneous squamous cell carcinoma (CSCC), non-small cell lung cancer (NSCLC), and basal cell carcinoma (BCC).
Libtayo is an immune checkpoint inhibitor that blocks the PD-1 protein, helping the immune system recognize and attack cancer cells.
Doctors prescribe Libtayo for adults with advanced CSCC, NSCLC with high PD-L1 expression, or BCC that has spread or cannot be treated with surgery or radiation.
Libtayo is given as an intravenous (IV) infusion, usually once every three weeks, under medical supervision.
Common side effects of Libtayo include fatigue, rash, diarrhea, nausea, muscle pain, and cough.
Yes, Libtayo may cause immune-related side effects, such as inflammation of the lungs, liver, intestines, or thyroid. Seek medical attention if you experience severe symptoms.
Libtayo is usually taken as long as it remains effective and well-tolerated, or until your doctor decides to stop the treatment.
It is best to avoid alcohol while taking Libtayo, as it may increase the risk of liver problems and worsen side effects.
No, Libtayo may harm an unborn baby. Women should use effective contraception while receiving this treatment.
Yes, Libtayo may interact with other drugs, especially those that affect the immune system. Inform your doctor about all medications you take.
If you miss a Libtayo infusion appointment, contact your doctor immediately to reschedule your treatment.
Libtayo is an IV infusion and is not taken orally, so food intake does not affect its administration.
Monitor for signs of immune-related side effects, avoid live vaccines, and inform your doctor of any existing health conditions before starting treatment.
Libtayo is stored and handled by healthcare professionals and should be kept in a controlled medical environment.
Libtayo is available by prescription and is administered in hospitals or cancer treatment centers. Consult your doctor for access to this medication. Pharma Five assists in its procurement.